期刊
CLINICAL AND EXPERIMENTAL DERMATOLOGY
卷 35, 期 4, 页码 397-398出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2230.2009.03476.x
关键词
-
类别
P>Patients with psoriasis and chronic hepatitis C virus (HCV) infection are a therapeutic challenge. Systemic psoriasis treatment with methotrexate and acitretin can be hepatotoxic, and interferon (IFN)-alpha for treatment of HCV can worsen psoriasis. Etanercept can be successfully used in patients with psoriasis and HCV. To our knowledge, this is the first case report of etanercept used prophylactically to prevent a psoriatic flare in a patient with HCV treated with IFN-alpha and ribavirin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据